speb/financial-data huggingface dataset:
DRX.L balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 23800000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 23800000.00
DRX.L cash_flow (annual, 2025-12-31) — Depreciation: 230600000.00
DRX.L cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 244800000.00
DRX.L income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 243100000.00
DRX.L income_statement (annual, 2025-12-31) — Depreciation Income Statement: 228900000.00
DRX.L balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 75600000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 75600000.00
DRX.L income_statement (annual, 2025-12-31) — Diluted Average Shares: 361300000.00
DRX.L income_statement (annual, 2025-12-31) — Diluted EPS: 0.20
DRX.L income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 73000000.00
DRX.L income_statement (annual, 2025-12-31) — EBIT: 263400000.00
DRX.L income_statement (annual, 2025-12-31) — EBITDA: 508200000.00
DRX.L cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 2200000.00
DRX.L cash_flow (annual, 2025-12-31) — End Cash Position: 302100000.00
DRX.L balance_sheet (annual, 2025-12-31) — Financial Assets: 24400000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Financial Assets: 24400000.00
DRX.L cash_flow (annual, 2025-12-31) — Financing Cash Flow: -578900000.00
DRX.L balance_sheet (annual, 2025-12-31) — Finished Goods: 167100000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Finished Goods: 167100000.00
DRX.L cash_flow (annual, 2025-12-31) — Free Cash Flow: 515800000.00
DRX.L cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 23400000.00
DRX.L cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 5400000.00
DRX.L balance_sheet (annual, 2025-12-31) — Goodwill: 396200000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Goodwill: 396200000.00
DRX.L balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 438900000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 438900000.00
DRX.L balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 26900000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 26900000.00
DRX.L balance_sheet (annual, 2025-12-31) — Gross PPE: 5290800000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Gross PPE: 5290800000.00
DRX.L income_statement (annual, 2025-12-31) — Gross Profit: 1512900000.00
DRX.L balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 68600000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 68600000.00
DRX.L income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 377700000.00
DRX.L income_statement (annual, 2025-12-31) — Interest Expense: 73900000.00
DRX.L income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 73900000.00
DRX.L income_statement (annual, 2025-12-31) — Interest Income: 17800000.00
DRX.L income_statement (annual, 2025-12-31) — Interest Income Non Operating: 17800000.00
DRX.L cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -96400000.00
DRX.L cash_flow (annual, 2025-12-31) — Interest Received Cfo: 16400000.00
DRX.L balance_sheet (annual, 2025-12-31) — Inventory: 223800000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Inventory: 223800000.00
DRX.L balance_sheet (annual, 2025-12-31) — Invested Capital: 2642100000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2642100000.00
DRX.L cash_flow (annual, 2025-12-31) — Investing Cash Flow: -287200000.00
DRX.L cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 5000000.00
DRX.L cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
DRX.L balance_sheet (annual, 2025-12-31) — Land And Improvements: 489700000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 489700000.00
DRX.L balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 120500000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 120500000.00
DRX.L balance_sheet (annual, 2025-12-31) — Long Term Debt: 867600000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 867600000.00
DRX.L balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 988100000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 988100000.00
DRX.L cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
DRX.L cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -233600000.00
DRX.L balance_sheet (annual, 2025-12-31) — Long Term Provisions: 85000000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 85000000.00
DRX.L balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 3928100000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3928100000.00
DRX.L balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
DRX.L income_statement (annual, 2025-12-31) — Minority Interests: 4800000.00
DRX.L cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -2000000.00
DRX.L cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -216100000.00
DRX.L balance_sheet (annual, 2025-12-31) — Net Debt: 626800000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Net Debt: 626800000.00
DRX.L cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -13600000.00
DRX.L income_statement (annual, 2025-12-31) — Net Income: 73000000.00
DRX.L income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 73000000.00
DRX.L income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 68200000.00
DRX.L income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 73000000.00
DRX.L income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 73000000.00
DRX.L cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 68200000.00
DRX.L income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 68200000.00
DRX.L cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -12200000.00
DRX.L income_statement (annual, 2025-12-31) — Net Interest Income: -56100000.00
DRX.L cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -233600000.00
DRX.L cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -233600000.00
DRX.L income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -56100000.00
DRX.L cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -5400000.00
DRX.L balance_sheet (annual, 2025-12-31) — Net PPE: 2496800000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Net PPE: 2496800000.00
DRX.L cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -273000000.00
DRX.L balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1274300000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1274300000.00
DRX.L balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 37000000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 37000000.00
DRX.L balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 261300000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 261300000.00
DRX.L income_statement (annual, 2025-12-31) — Normalized EBITDA: 890700000.00
DRX.L income_statement (annual, 2025-12-31) — Normalized Income: 359875000.00
DRX.L cash_flow (annual, 2025-12-31) — Operating Cash Flow: 810000000.00
DRX.L income_statement (annual, 2025-12-31) — Operating Income: 631900000.00
DRX.L income_statement (annual, 2025-12-31) — Operating Revenue: 5390700000.00
DRX.L balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 340383358.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 340383358.00
DRX.L balance_sheet (annual, 2025-12-31) — Other Current Assets: 542100000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 542100000.00
DRX.L balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 42700000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 42700000.00
DRX.L cash_flow (annual, 2025-12-31) — Other Non Cash Items: 67300000.00
DRX.L income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -8000000.00
DRX.L income_statement (annual, 2025-12-31) — Other Operating Expenses: 321000000.00
DRX.L balance_sheet (annual, 2025-12-31) — Other Payable: 189900000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Other Payable: 189900000.00
DRX.L balance_sheet (annual, 2025-12-31) — Other Receivables: 288300000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Other Receivables: 288300000.00
DRX.L income_statement (annual, 2025-12-31) — Other Special Charges: 1500000.00
DRX.L income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
DRX.L balance_sheet (annual, 2025-12-31) — Payables: 340600000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Payables: 340600000.00
DRX.L balance_sheet (annual, 2025-12-31) — Prepaid Assets: 22600000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 22600000.00
DRX.L income_statement (annual, 2025-12-31) — Pretax Income: 189500000.00
DRX.L balance_sheet (annual, 2025-12-31) — Properties: 0.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
DRX.L cash_flow (annual, 2025-12-31) — Purchase Of Business: -2000000.00
DRX.L cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -12200000.00
DRX.L cash_flow (annual, 2025-12-31) — Purchase Of PPE: -282000000.00
DRX.L balance_sheet (annual, 2025-12-31) — Raw Materials: 56700000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Raw Materials: 56700000.00
DRX.L income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 3877800000.00
DRX.L income_statement (annual, 2025-12-31) — Reconciled Depreciation: 244800000.00
DRX.L cash_flow (annual, 2025-12-31) — Repayment Of Debt: -233600000.00
DRX.L cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -221100000.00
DRX.L balance_sheet (annual, 2025-12-31) — Retained Earnings: 1110900000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1110900000.00
DRX.L cash_flow (annual, 2025-12-31) — Sale Of PPE: 9000000.00
DRX.L balance_sheet (annual, 2025-12-31) — Share Issued: 432171763.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 432171763.00
DRX.L income_statement (annual, 2025-12-31) — Special Income Charges: -382500000.00
DRX.L cash_flow (annual, 2025-12-31) — Stock Based Compensation: 15700000.00
DRX.L balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1713200000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1713200000.00
DRX.L balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1274300000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1274300000.00
DRX.L income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -95625000.00
DRX.L income_statement (annual, 2025-12-31) — Tax Provision: 121300000.00
DRX.L income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
DRX.L balance_sheet (annual, 2025-12-31) — Taxes Receivable: 100000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 100000.00
DRX.L cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -109500000.00
DRX.L balance_sheet (annual, 2025-12-31) — Total Assets: 4495400000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 4495400000.00
DRX.L balance_sheet (annual, 2025-12-31) — Total Capitalization: 2580800000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2580800000.00
DRX.L balance_sheet (annual, 2025-12-31) — Total Debt: 1077600000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Total Debt: 1077600000.00
DRX.L balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1713200000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1713200000.00
DRX.L income_statement (annual, 2025-12-31) — Total Expenses: 4758800000.00
DRX.L balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2782200000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2782200000.00
DRX.L balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3020900000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3020900000.00
DRX.L balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1410000000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1410000000.00
DRX.L income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 241300000.00
DRX.L balance_sheet (annual, 2025-12-31) — Total Tax Payable: 0.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 0.00
DRX.L income_statement (annual, 2025-12-31) — Total Unusual Items: -382500000.00
DRX.L income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -382500000.00
DRX.L balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 91788405.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 91788405.00
DRX.L balance_sheet (annual, 2025-12-31) — Treasury Stock: 534600000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 534600000.00
DRX.L balance_sheet (annual, 2025-12-31) — Working Capital: 102300000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Working Capital: 102300000.00
DRX.L income_statement (annual, 2025-12-31) — Write Off: 3300000.00
DRX.TO cash_flow (annual, 2022-01-31) — Common Stock Dividend Paid: -653000.00
DRX.TO cash_flow (annual, 2022-01-31) — Gain Loss On Sale Of PPE: -2111000.00
DRX.TO cash_flow (annual, 2022-01-31) — Issuance Of Debt: 30000000.00
DRX.TO balance_sheet (annual, 2022-01-31) — Leases: 603000.00
DRX.TO cash_flow (annual, 2022-01-31) — Long Term Debt Issuance: 30000000.00
DRX.TO balance_sheet (annual, 2022-01-31) — Net Debt: 21572000.00
DRX.TO cash_flow (annual, 2022-01-31) — Net Other Financing Charges: -316000.00
DRX.TO cash_flow (annual, 2022-01-31) — Net Short Term Debt Issuance: 0.00
DRX.TO balance_sheet (annual, 2022-01-31) — Other Non Current Assets: 1375000.00
DRX.TO balance_sheet (annual, 2022-01-31) — Prepaid Assets: 2312000.00
DRX.TO cash_flow (annual, 2022-01-31) — Short Term Debt Payments: 0.00
DRX.TO income_statement (annual, 2023-01-31) — +Operating Expense: 14773000.00
DRX.TO income_statement (annual, 2023-01-31) — +Total Revenue: 250890000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Accounts Payable: 18807000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Accounts Receivable: 75793000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Accumulated Depreciation: -60728000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Additional Paid In Capital: 6435000.00
DRX.TO cash_flow (annual, 2023-01-31) — Amortization Cash Flow: 370000.00
DRX.TO cash_flow (annual, 2023-01-31) — Amortization Of Intangibles: 370000.00
DRX.TO income_statement (annual, 2023-01-31) — Basic Average Shares: 32640000.00
DRX.TO income_statement (annual, 2023-01-31) — Basic EPS: 0.46
DRX.TO cash_flow (annual, 2023-01-31) — Beginning Cash Position: 7130000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Buildings And Improvements: 92006000.00
DRX.TO cash_flow (annual, 2023-01-31) — Capital Expenditure: -12161000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Capital Lease Obligations: 4334000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Capital Stock: 68127000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Cash And Cash Equivalents: 7193000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Cash Cash Equivalents And Short Term Investments: 7193000.00
DRX.TO cash_flow (annual, 2023-01-31) — Cash Dividends Paid: -653000.00
DRX.TO cash_flow (annual, 2023-01-31) — Cash Flow From Continuing Financing Activities: 14157000.00
DRX.TO cash_flow (annual, 2023-01-31) — Cash Flow From Continuing Investing Activities: -12081000.00
DRX.TO cash_flow (annual, 2023-01-31) — Cash Flow From Continuing Operating Activities: -2612000.00
DRX.TO cash_flow (annual, 2023-01-31) — Change In Account Payable: 5478000.00
DRX.TO cash_flow (annual, 2023-01-31) — Change In Inventory: -550000.00
DRX.TO cash_flow (annual, 2023-01-31) — Change In Other Working Capital: 29777000.00
DRX.TO cash_flow (annual, 2023-01-31) — Change In Payable: 5478000.00
DRX.TO cash_flow (annual, 2023-01-31) — Change In Payables And Accrued Expense: 5478000.00
DRX.TO cash_flow (annual, 2023-01-31) — Change In Prepaid Assets: 103000.00
DRX.TO cash_flow (annual, 2023-01-31) — Change In Receivables: -60658000.00
DRX.TO cash_flow (annual, 2023-01-31) — Change In Working Capital: -25850000.00
DRX.TO cash_flow (annual, 2023-01-31) — Changes In Account Receivables: -48647000.00
DRX.TO cash_flow (annual, 2023-01-31) — Changes In Cash: -536000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Common Stock: 68127000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Common Stock Equity: 124985000.00
DRX.TO income_statement (annual, 2023-01-31) — Cost Of Revenue: 215321000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Current Accrued Expenses: 15808000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Current Assets: 154380000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Current Capital Lease Obligation: 806000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Current Debt And Capital Lease Obligation: 3064000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Current Deferred Liabilities: 44533000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Current Deferred Revenue: 44533000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Current Liabilities: 88781000.00
DRX.TO cash_flow (annual, 2023-01-31) — Deferred Income Tax: 1919000.00
DRX.TO cash_flow (annual, 2023-01-31) — Deferred Tax: 1919000.00
DRX.TO cash_flow (annual, 2023-01-31) — Depreciation: 4953000.00
DRX.TO cash_flow (annual, 2023-01-31) — Depreciation Amortization Depletion: 5323000.00
DRX.TO cash_flow (annual, 2023-01-31) — Depreciation And Amortization: 5323000.00
DRX.TO income_statement (annual, 2023-01-31) — Diluted Average Shares: 32640000.00
DRX.TO income_statement (annual, 2023-01-31) — Diluted EPS: 0.46
DRX.TO income_statement (annual, 2023-01-31) — Diluted NI Availto Com Stockholders: 14935000.00
DRX.TO income_statement (annual, 2023-01-31) — EBIT: 18831000.00
DRX.TO income_statement (annual, 2023-01-31) — EBITDA: 24154000.00
DRX.TO cash_flow (annual, 2023-01-31) — Effect Of Exchange Rate Changes: 599000.00
DRX.TO cash_flow (annual, 2023-01-31) — End Cash Position: 7193000.00
DRX.TO cash_flow (annual, 2023-01-31) — Financing Cash Flow: 14157000.00
DRX.TO cash_flow (annual, 2023-01-31) — Free Cash Flow: -14773000.00
DRX.TO cash_flow (annual, 2023-01-31) — Gain Loss On Investment Securities: 968000.00
DRX.TO cash_flow (annual, 2023-01-31) — Gain Loss On Sale Of PPE: -802000.00
DRX.TO income_statement (annual, 2023-01-31) — Gain On Sale Of Security: -1943000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Gains Losses Not Affecting Retained Earnings: 8107000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Goodwill And Other Intangible Assets: 3640000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Gross PPE: 172954000.00
DRX.TO income_statement (annual, 2023-01-31) — Gross Profit: 35569000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Income Tax Payable: 235000.00
DRX.TO income_statement (annual, 2023-01-31) — Interest Expense: 1977000.00
DRX.TO income_statement (annual, 2023-01-31) — Interest Expense Non Operating: 1977000.00
DRX.TO cash_flow (annual, 2023-01-31) — Interest Paid Cff: -2177000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Inventories Adjustments Allowances: -618000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Inventory: 10679000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Invested Capital: 169912000.00
DRX.TO cash_flow (annual, 2023-01-31) — Investing Cash Flow: -12081000.00
DRX.TO cash_flow (annual, 2023-01-31) — Issuance Of Debt: 20000000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Land And Improvements: 7854000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Leases: 0.00
DRX.TO balance_sheet (annual, 2023-01-31) — Long Term Capital Lease Obligation: 3528000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Long Term Debt: 44927000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Long Term Debt And Capital Lease Obligation: 48455000.00
DRX.TO cash_flow (annual, 2023-01-31) — Long Term Debt Issuance: 20000000.00
DRX.TO cash_flow (annual, 2023-01-31) — Long Term Debt Payments: -3020000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Machinery Furniture Equipment: 10137000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Net Debt: 37734000.00
DRX.TO cash_flow (annual, 2023-01-31) — Net Foreign Currency Exchange Gain Loss: -1158000.00
DRX.TO income_statement (annual, 2023-01-31) — Net Income: 14935000.00
DRX.TO income_statement (annual, 2023-01-31) — Net Income Common Stockholders: 14935000.00
DRX.TO income_statement (annual, 2023-01-31) — Net Income Continuous Operations: 14935000.00
DRX.TO income_statement (annual, 2023-01-31) — Net Income From Continuing And Discontinued Operation: 14935000.00
DRX.TO income_statement (annual, 2023-01-31) — Net Income From Continuing Operation Net Minority Interest: 14935000.00
DRX.TO cash_flow (annual, 2023-01-31) — Net Income From Continuing Operations: 14935000.00
DRX.TO income_statement (annual, 2023-01-31) — Net Income Including Noncontrolling Interests: 14935000.00
DRX.TO cash_flow (annual, 2023-01-31) — Net Intangibles Purchase And Sale: -698000.00
DRX.TO income_statement (annual, 2023-01-31) — Net Interest Income: -1999000.00
DRX.TO cash_flow (annual, 2023-01-31) — Net Issuance Payments Of Debt: 16980000.00
DRX.TO cash_flow (annual, 2023-01-31) — Net Long Term Debt Issuance: 16980000.00
DRX.TO income_statement (annual, 2023-01-31) — Net Non Operating Interest Income Expense: -1999000.00
DRX.TO cash_flow (annual, 2023-01-31) — Net Other Financing Charges: 7000.00
DRX.TO cash_flow (annual, 2023-01-31) — Net Other Investing Changes: 80000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Net PPE: 112226000.00
DRX.TO cash_flow (annual, 2023-01-31) — Net PPE Purchase And Sale: -11463000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Net Tangible Assets: 121345000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Non Current Deferred Assets: 0.00
DRX.TO balance_sheet (annual, 2023-01-31) — Non Current Deferred Liabilities: 9240000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Non Current Deferred Taxes Assets: 0.00
DRX.TO balance_sheet (annual, 2023-01-31) — Non Current Deferred Taxes Liabilities: 9240000.00
DRX.TO income_statement (annual, 2023-01-31) — Normalized EBITDA: 26097000.00
DRX.TO income_statement (annual, 2023-01-31) — Normalized Income: 16656692.30
DRX.TO cash_flow (annual, 2023-01-31) — Operating Cash Flow: -2612000.00
DRX.TO cash_flow (annual, 2023-01-31) — Operating Gains Losses: -992000.00
DRX.TO income_statement (annual, 2023-01-31) — Operating Income: 20796000.00
DRX.TO income_statement (annual, 2023-01-31) — Operating Revenue: 250890000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Ordinary Shares Number: 32640206.00
DRX.TO balance_sheet (annual, 2023-01-31) — Other Current Assets: 2332000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Other Current Liabilities: 964000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Other Equity Adjustments: 8107000.00
DRX.TO income_statement (annual, 2023-01-31) — Other Income Expense: -1943000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Other Intangible Assets: 3640000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Other Inventories: 11297000.00
DRX.TO cash_flow (annual, 2023-01-31) — Other Non Cash Items: 469000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Other Non Current Assets: 1371000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Other Non Current Liabilities: 156000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Other Properties: 62957000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Other Receivables: 57669000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Payables: 22927000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Payables And Accrued Expenses: 38735000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 1485000.00
DRX.TO income_statement (annual, 2023-01-31) — Pretax Income: 16854000.00
DRX.TO cash_flow (annual, 2023-01-31) — Purchase Of Intangibles: -698000.00
DRX.TO cash_flow (annual, 2023-01-31) — Purchase Of PPE: -11463000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Receivables: 134176000.00
DRX.TO income_statement (annual, 2023-01-31) — Reconciled Cost Of Revenue: 215321000.00
DRX.TO income_statement (annual, 2023-01-31) — Reconciled Depreciation: 5323000.00
DRX.TO cash_flow (annual, 2023-01-31) — Repayment Of Debt: -3020000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Retained Earnings: 42316000.00
DRX.TO income_statement (annual, 2023-01-31) — Selling General And Administration: 14773000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Share Issued: 32640206.00
DRX.TO cash_flow (annual, 2023-01-31) — Stock Based Compensation: 724000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Stockholders Equity: 124985000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Tangible Book Value: 121345000.00
DRX.TO income_statement (annual, 2023-01-31) — Tax Effect Of Unusual Items: -221307.70
DRX.TO income_statement (annual, 2023-01-31) — Tax Provision: 1919000.00
DRX.TO income_statement (annual, 2023-01-31) — Tax Rate For Calcs: 0.11
DRX.TO balance_sheet (annual, 2023-01-31) — Taxes Receivable: 714000.00
DRX.TO cash_flow (annual, 2023-01-31) — Taxes Refund Paid: 860000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Total Assets: 271617000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Total Capitalization: 169912000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Total Debt: 51519000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Total Equity Gross Minority Interest: 124985000.00
DRX.TO income_statement (annual, 2023-01-31) — Total Expenses: 230094000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Total Liabilities Net Minority Interest: 146632000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Total Non Current Assets: 117237000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Total Non Current Liabilities Net Minority Interest: 57851000.00
DRX.TO income_statement (annual, 2023-01-31) — Total Other Finance Cost: 22000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Total Tax Payable: 4120000.00
DRX.TO income_statement (annual, 2023-01-31) — Total Unusual Items: -1943000.00
DRX.TO income_statement (annual, 2023-01-31) — Total Unusual Items Excluding Goodwill: -1943000.00
DRX.TO balance_sheet (annual, 2023-01-31) — Working Capital: 65599000.00
DRX.TO income_statement (annual, 2024-01-31) — +Operating Expense: 22782000.00
DRX.TO income_statement (annual, 2024-01-31) — +Total Revenue: 331023000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Accounts Payable: 24441000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Accounts Receivable: 63119000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Accumulated Depreciation: -64971000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Additional Paid In Capital: 6435000.00
DRX.TO cash_flow (annual, 2024-01-31) — Amortization Cash Flow: 435000.00
DRX.TO cash_flow (annual, 2024-01-31) — Amortization Of Intangibles: 435000.00
DRX.TO income_statement (annual, 2024-01-31) — Basic Average Shares: 32640000.00
DRX.TO income_statement (annual, 2024-01-31) — Basic EPS: 1.15
DRX.TO cash_flow (annual, 2024-01-31) — Beginning Cash Position: 7193000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Buildings And Improvements: 94494000.00
DRX.TO cash_flow (annual, 2024-01-31) — Capital Expenditure: -6488000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Capital Lease Obligations: 3666000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Capital Stock: 68127000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Cash And Cash Equivalents: 72379000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Cash Cash Equivalents And Short Term Investments: 72379000.00
DRX.TO cash_flow (annual, 2024-01-31) — Cash Dividends Paid: -653000.00
DRX.TO cash_flow (annual, 2024-01-31) — Cash Flow From Continuing Financing Activities: -6688000.00
DRX.TO cash_flow (annual, 2024-01-31) — Cash Flow From Continuing Investing Activities: -6266000.00
DRX.TO cash_flow (annual, 2024-01-31) — Cash Flow From Continuing Operating Activities: 77860000.00
DRX.TO cash_flow (annual, 2024-01-31) — Change In Account Payable: 10749000.00
DRX.TO cash_flow (annual, 2024-01-31) — Change In Inventory: -2849000.00
DRX.TO cash_flow (annual, 2024-01-31) — Change In Other Working Capital: 1103000.00
DRX.TO cash_flow (annual, 2024-01-31) — Change In Payable: 10749000.00
DRX.TO cash_flow (annual, 2024-01-31) — Change In Payables And Accrued Expense: 10749000.00
DRX.TO cash_flow (annual, 2024-01-31) — Change In Prepaid Assets: -1213000.00
DRX.TO cash_flow (annual, 2024-01-31) — Change In Receivables: 11372000.00
DRX.TO cash_flow (annual, 2024-01-31) — Change In Working Capital: 19162000.00
DRX.TO cash_flow (annual, 2024-01-31) — Changes In Account Receivables: 13589000.00
DRX.TO cash_flow (annual, 2024-01-31) — Changes In Cash: 64906000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Common Stock: 68127000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Common Stock Equity: 162130000.00
DRX.TO cash_flow (annual, 2024-01-31) — Common Stock Payments: 0.00
DRX.TO income_statement (annual, 2024-01-31) — Cost Of Revenue: 258102000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Current Accrued Expenses: 23638000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Current Assets: 215576000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Current Capital Lease Obligation: 827000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Current Debt And Capital Lease Obligation: 3867000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Current Deferred Liabilities: 46168000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Current Deferred Revenue: 46168000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Current Liabilities: 105476000.00
DRX.TO cash_flow (annual, 2024-01-31) — Deferred Income Tax: 8784000.00
DRX.TO cash_flow (annual, 2024-01-31) — Deferred Tax: 8784000.00
DRX.TO cash_flow (annual, 2024-01-31) — Depreciation: 5365000.00
DRX.TO cash_flow (annual, 2024-01-31) — Depreciation Amortization Depletion: 5800000.00
DRX.TO cash_flow (annual, 2024-01-31) — Depreciation And Amortization: 5800000.00
DRX.TO income_statement (annual, 2024-01-31) — Diluted Average Shares: 32640000.00
DRX.TO income_statement (annual, 2024-01-31) — Diluted EPS: 1.15
DRX.TO income_statement (annual, 2024-01-31) — Diluted NI Availto Com Stockholders: 37622000.00
DRX.TO income_statement (annual, 2024-01-31) — EBIT: 50019000.00
DRX.TO income_statement (annual, 2024-01-31) — EBITDA: 55819000.00
DRX.TO cash_flow (annual, 2024-01-31) — Effect Of Exchange Rate Changes: 280000.00
DRX.TO cash_flow (annual, 2024-01-31) — End Cash Position: 72379000.00
DRX.TO cash_flow (annual, 2024-01-31) — Financing Cash Flow: -6688000.00
DRX.TO cash_flow (annual, 2024-01-31) — Free Cash Flow: 71372000.00
DRX.TO cash_flow (annual, 2024-01-31) — Gain Loss On Investment Securities: -1168000.00
DRX.TO cash_flow (annual, 2024-01-31) — Gain Loss On Sale Of PPE: -31000.00
DRX.TO income_statement (annual, 2024-01-31) — Gain On Sale Of Security: -1160000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Gains Losses Not Affecting Retained Earnings: 8283000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Goodwill And Other Intangible Assets: 3925000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Gross PPE: 172759000.00
DRX.TO income_statement (annual, 2024-01-31) — Gross Profit: 72921000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Income Tax Payable: 0.00
DRX.TO income_statement (annual, 2024-01-31) — Interest Expense: 3613000.00
DRX.TO income_statement (annual, 2024-01-31) — Interest Expense Non Operating: 3613000.00
DRX.TO income_statement (annual, 2024-01-31) — Interest Income: 1363000.00
DRX.TO income_statement (annual, 2024-01-31) — Interest Income Non Operating: 1363000.00
DRX.TO cash_flow (annual, 2024-01-31) — Interest Paid Cff: -3053000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Inventories Adjustments Allowances: -1583000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Inventory: 13534000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Invested Capital: 204268000.00
DRX.TO cash_flow (annual, 2024-01-31) — Investing Cash Flow: -6266000.00
DRX.TO cash_flow (annual, 2024-01-31) — Issuance Of Debt: 0.00
DRX.TO balance_sheet (annual, 2024-01-31) — Land And Improvements: 7867000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Long Term Capital Lease Obligation: 2839000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Long Term Debt: 42138000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Long Term Debt And Capital Lease Obligation: 44977000.00
DRX.TO cash_flow (annual, 2024-01-31) — Long Term Debt Issuance: 0.00
DRX.TO cash_flow (annual, 2024-01-31) — Long Term Debt Payments: -2982000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Machinery Furniture Equipment: 10126000.00
DRX.TO cash_flow (annual, 2024-01-31) — Net Common Stock Issuance: 0.00
DRX.TO cash_flow (annual, 2024-01-31) — Net Foreign Currency Exchange Gain Loss: -176000.00
DRX.TO income_statement (annual, 2024-01-31) — Net Income: 37622000.00
DRX.TO income_statement (annual, 2024-01-31) — Net Income Common Stockholders: 37622000.00
DRX.TO income_statement (annual, 2024-01-31) — Net Income Continuous Operations: 37622000.00
DRX.TO income_statement (annual, 2024-01-31) — Net Income From Continuing And Discontinued Operation: 37622000.00
DRX.TO income_statement (annual, 2024-01-31) — Net Income From Continuing Operation Net Minority Interest: 37622000.00
DRX.TO cash_flow (annual, 2024-01-31) — Net Income From Continuing Operations: 37622000.00
DRX.TO income_statement (annual, 2024-01-31) — Net Income Including Noncontrolling Interests: 37622000.00
DRX.TO cash_flow (annual, 2024-01-31) — Net Intangibles Purchase And Sale: -720000.00
DRX.TO income_statement (annual, 2024-01-31) — Net Interest Income: -2573000.00
DRX.TO cash_flow (annual, 2024-01-31) — Net Issuance Payments Of Debt: -2982000.00
DRX.TO cash_flow (annual, 2024-01-31) — Net Long Term Debt Issuance: -2982000.00
DRX.TO income_statement (annual, 2024-01-31) — Net Non Operating Interest Income Expense: -2573000.00
DRX.TO cash_flow (annual, 2024-01-31) — Net Other Investing Changes: 222000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Net PPE: 107788000.00
DRX.TO cash_flow (annual, 2024-01-31) — Net PPE Purchase And Sale: -5768000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Net Tangible Assets: 158205000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Non Current Deferred Assets: 266000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Non Current Deferred Liabilities: 15876000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Non Current Deferred Taxes Assets: 266000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Non Current Deferred Taxes Liabilities: 15876000.00
DRX.TO income_statement (annual, 2024-01-31) — Normalized EBITDA: 56979000.00
DRX.TO income_statement (annual, 2024-01-31) — Normalized Income: 38562428.39
DRX.TO cash_flow (annual, 2024-01-31) — Operating Cash Flow: 77860000.00
DRX.TO cash_flow (annual, 2024-01-31) — Operating Gains Losses: -1344000.00
DRX.TO income_statement (annual, 2024-01-31) — Operating Income: 50139000.00
DRX.TO income_statement (annual, 2024-01-31) — Operating Revenue: 331023000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Ordinary Shares Number: 32640206.00
DRX.TO balance_sheet (annual, 2024-01-31) — Other Current Assets: 3730000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Other Equity Adjustments: 8283000.00
DRX.TO income_statement (annual, 2024-01-31) — Other Income Expense: -1160000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Other Intangible Assets: 3925000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Other Inventories: 15117000.00
DRX.TO cash_flow (annual, 2024-01-31) — Other Non Cash Items: 3353000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Other Non Current Assets: 1050000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Other Non Current Liabilities: 146000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Other Properties: 60272000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Other Receivables: 59587000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Payables: 25971000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Payables And Accrued Expenses: 49609000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 5832000.00
DRX.TO income_statement (annual, 2024-01-31) — Pretax Income: 46406000.00
DRX.TO cash_flow (annual, 2024-01-31) — Purchase Of Intangibles: -720000.00
DRX.TO cash_flow (annual, 2024-01-31) — Purchase Of PPE: -5768000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Receivables: 125933000.00
DRX.TO income_statement (annual, 2024-01-31) — Reconciled Cost Of Revenue: 258102000.00
DRX.TO income_statement (annual, 2024-01-31) — Reconciled Depreciation: 5800000.00
DRX.TO cash_flow (annual, 2024-01-31) — Repayment Of Debt: -2982000.00
DRX.TO cash_flow (annual, 2024-01-31) — Repurchase Of Capital Stock: 0.00
DRX.TO balance_sheet (annual, 2024-01-31) — Retained Earnings: 79285000.00
DRX.TO income_statement (annual, 2024-01-31) — Selling General And Administration: 22782000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Share Issued: 32640206.00
DRX.TO cash_flow (annual, 2024-01-31) — Stock Based Compensation: 4576000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Stockholders Equity: 162130000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Tangible Book Value: 158205000.00
DRX.TO income_statement (annual, 2024-01-31) — Tax Effect Of Unusual Items: -219571.61
DRX.TO income_statement (annual, 2024-01-31) — Tax Provision: 8784000.00
DRX.TO income_statement (annual, 2024-01-31) — Tax Rate For Calcs: 0.19
DRX.TO balance_sheet (annual, 2024-01-31) — Taxes Receivable: 3227000.00
DRX.TO cash_flow (annual, 2024-01-31) — Taxes Refund Paid: -93000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Total Assets: 328605000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Total Capitalization: 204268000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Total Debt: 48844000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Total Equity Gross Minority Interest: 162130000.00
DRX.TO income_statement (annual, 2024-01-31) — Total Expenses: 280884000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Total Liabilities Net Minority Interest: 166475000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Total Non Current Assets: 113029000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Total Non Current Liabilities Net Minority Interest: 60999000.00
DRX.TO income_statement (annual, 2024-01-31) — Total Other Finance Cost: 323000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Total Tax Payable: 1530000.00
DRX.TO income_statement (annual, 2024-01-31) — Total Unusual Items: -1160000.00
DRX.TO income_statement (annual, 2024-01-31) — Total Unusual Items Excluding Goodwill: -1160000.00
DRX.TO balance_sheet (annual, 2024-01-31) — Working Capital: 110100000.00
DRX.TO cash_flow (quarterly, 2024-10-31) — Amortization Cash Flow: 126000.00
DRX.TO cash_flow (quarterly, 2024-10-31) — Amortization Of Intangibles: 126000.00
DRX.TO income_statement (quarterly, 2024-10-31) — Basic Average Shares: 29874000.00
DRX.TO income_statement (quarterly, 2024-10-31) — Basic EPS: 0.55
DRX.TO cash_flow (quarterly, 2024-10-31) — Common Stock Dividend Paid: -598000.00
DRX.TO cash_flow (quarterly, 2024-10-31) — Common Stock Payments: -100000.00
DRX.TO balance_sheet (quarterly, 2024-10-31) — Current Debt: 3902000.00
DRX.TO income_statement (quarterly, 2024-10-31) — Diluted Average Shares: 29874000.00
DRX.TO income_statement (quarterly, 2024-10-31) — Diluted EPS: 0.55
DRX.TO cash_flow (quarterly, 2024-10-31) — Net Business Purchase And Sale: 0.00
DRX.TO cash_flow (quarterly, 2024-10-31) — Net Common Stock Issuance: -100000.00
DRX.TO cash_flow (quarterly, 2024-10-31) — Net Short Term Debt Issuance: -100000.00
DRX.TO balance_sheet (quarterly, 2024-10-31) — Non Current Deferred Assets: 0.00
DRX.TO balance_sheet (quarterly, 2024-10-31) — Non Current Deferred Taxes Assets: 0.00
DRX.TO balance_sheet (quarterly, 2024-10-31) — Other Current Borrowings: 3902000.00
DRX.TO balance_sheet (quarterly, 2024-10-31) — Other Current Liabilities: 2541000.00
DRX.TO balance_sheet (quarterly, 2024-10-31) — Other Non Current Assets: 10000.00
DRX.TO cash_flow (quarterly, 2024-10-31) — Purchase Of Business: 0.00
DRX.TO cash_flow (quarterly, 2024-10-31) — Repurchase Of Capital Stock: -100000.00
DRX.TO cash_flow (quarterly, 2024-10-31) — Short Term Debt Payments: -100000.00
DRX.TO cash_flow (quarterly, 2024-10-31) — Taxes Refund Paid: -3457000.00
DRX.TO income_statement (annual, 2025-01-31) — +Operating Expense: 22112000.00
DRX.TO income_statement (quarterly, 2025-01-31) — +Operating Expense: 6361000.00
DRX.TO income_statement (annual, 2025-01-31) — +Total Revenue: 339632000.00
DRX.TO income_statement (quarterly, 2025-01-31) — +Total Revenue: 77399000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Accounts Payable: 20965000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 20965000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Accounts Receivable: 68030000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Accounts Receivable: 68030000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Accumulated Depreciation: -71588000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Accumulated Depreciation: -71588000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Additional Paid In Capital: 6179000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 6179000.00
DRX.TO cash_flow (annual, 2025-01-31) — Amortization Cash Flow: 498000.00
DRX.TO cash_flow (annual, 2025-01-31) — Amortization Of Intangibles: 498000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Assets Held For Sale Current: 0.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Assets Held For Sale Current: 0.00
DRX.TO income_statement (annual, 2025-01-31) — Basic Average Shares: 30852000.00
DRX.TO income_statement (annual, 2025-01-31) — Basic EPS: 1.84
DRX.TO cash_flow (annual, 2025-01-31) — Beginning Cash Position: 72379000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 65483000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Buildings And Improvements: 102222000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Buildings And Improvements: 102222000.00
DRX.TO cash_flow (annual, 2025-01-31) — Capital Expenditure: -9093000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Capital Expenditure: -1445000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Capital Lease Obligations: 3244000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Capital Lease Obligations: 3244000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Capital Stock: 61754000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Capital Stock: 61754000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Cash And Cash Equivalents: 59983000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 59983000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 59983000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 59983000.00
DRX.TO cash_flow (annual, 2025-01-31) — Cash Dividends Paid: -924000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Cash Dividends Paid: 0.00
DRX.TO cash_flow (annual, 2025-01-31) — Cash Flow From Continuing Financing Activities: -62069000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: -7569000.00
DRX.TO cash_flow (annual, 2025-01-31) — Cash Flow From Continuing Investing Activities: -8709000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: -1385000.00
DRX.TO cash_flow (annual, 2025-01-31) — Cash Flow From Continuing Operating Activities: 55056000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: 1758000.00
DRX.TO cash_flow (annual, 2025-01-31) — Change In Account Payable: -9398000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Change In Account Payable: -7872000.00
DRX.TO cash_flow (annual, 2025-01-31) — Change In Inventory: 244000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Change In Inventory: -907000.00
DRX.TO cash_flow (annual, 2025-01-31) — Change In Other Current Assets: 776000.00
DRX.TO cash_flow (annual, 2025-01-31) — Change In Other Working Capital: -36400000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Change In Other Working Capital: -4704000.00
DRX.TO cash_flow (annual, 2025-01-31) — Change In Payable: -9398000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Change In Payable: -7872000.00
DRX.TO cash_flow (annual, 2025-01-31) — Change In Payables And Accrued Expense: -9398000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: -7872000.00
DRX.TO cash_flow (annual, 2025-01-31) — Change In Prepaid Assets: -658000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Change In Prepaid Assets: 1253000.00
DRX.TO cash_flow (annual, 2025-01-31) — Change In Receivables: 20369000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Change In Receivables: 1734000.00
DRX.TO cash_flow (annual, 2025-01-31) — Change In Working Capital: -25067000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Change In Working Capital: -10496000.00
DRX.TO cash_flow (annual, 2025-01-31) — Changes In Account Receivables: 159000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Changes In Account Receivables: -1923000.00
DRX.TO cash_flow (annual, 2025-01-31) — Changes In Cash: -15722000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Changes In Cash: -7196000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Common Stock: 61754000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Common Stock: 61754000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Common Stock Equity: 169312000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 169312000.00
DRX.TO cash_flow (annual, 2025-01-31) — Common Stock Payments: -54574000.00
DRX.TO income_statement (annual, 2025-01-31) — Cost Of Revenue: 232391000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Cost Of Revenue: 53402000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Current Accrued Expenses: 20804000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Current Accrued Expenses: 20804000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Current Assets: 189564000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Current Assets: 189564000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Current Capital Lease Obligation: 821000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Current Capital Lease Obligation: 821000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Current Debt And Capital Lease Obligation: 4998000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Current Debt And Capital Lease Obligation: 4998000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Current Deferred Liabilities: 11484000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Current Deferred Liabilities: 11484000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Current Deferred Revenue: 11484000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Current Deferred Revenue: 11484000.00
DRX.TO balance_sheet (annual, 2025-01-31) — Current Liabilities: 80370000.00
DRX.TO balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 80370000.00
DRX.TO cash_flow (annual, 2025-01-31) — Deferred Income Tax: 20016000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Deferred Income Tax: 4039000.00
DRX.TO cash_flow (annual, 2025-01-31) — Deferred Tax: 20016000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Deferred Tax: 4039000.00
DRX.TO cash_flow (annual, 2025-01-31) — Depreciation: 5662000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Depreciation: 1110000.00
DRX.TO cash_flow (annual, 2025-01-31) — Depreciation Amortization Depletion: 6160000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 1608000.00
DRX.TO cash_flow (annual, 2025-01-31) — Depreciation And Amortization: 6160000.00
DRX.TO cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 1608000.00
DRX.TO income_statement (annual, 2025-01-31) — Diluted Average Shares: 30852000.00
DRX.TO income_statement (annual, 2025-01-31) — Diluted EPS: 1.84
DRX.TO income_statement (annual, 2025-01-31) — Diluted NI Availto Com Stockholders: 56790000.00
DRX.TO income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: 9093000.00
DRX.TO income_statement (annual, 2025-01-31) — EBIT: 81724000.00